BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 16046394)

  • 21. PIAS3 negatively regulates RANKL-mediated osteoclastogenesis directly in osteoclast precursors and indirectly via osteoblasts.
    Hikata T; Takaishi H; Takito J; Hakozaki A; Furukawa M; Uchikawa S; Kimura T; Okada Y; Matsumoto M; Yoshimura A; Nishimura R; Reddy SV; Asahara H; Toyama Y
    Blood; 2009 Mar; 113(10):2202-12. PubMed ID: 18952894
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Arctigenin inhibits osteoclast differentiation and function by suppressing both calcineurin-dependent and osteoblastic cell-dependent NFATc1 pathways.
    Yamashita T; Uehara S; Udagawa N; Li F; Kadota S; Esumi H; Kobayashi Y; Takahashi N
    PLoS One; 2014; 9(1):e85878. PubMed ID: 24465763
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CTRP3 acts as a negative regulator of osteoclastogenesis through AMPK-c-Fos-NFATc1 signaling in vitro and RANKL-induced calvarial bone destruction in vivo.
    Kim JY; Min JY; Baek JM; Ahn SJ; Jun HY; Yoon KH; Choi MK; Lee MS; Oh J
    Bone; 2015 Oct; 79():242-51. PubMed ID: 26103094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cooperation of PU.1 With IRF8 and NFATc1 Defines Chromatin Landscapes During RANKL-Induced Osteoclastogenesis.
    Izawa N; Kurotaki D; Nomura S; Fujita T; Omata Y; Yasui T; Hirose J; Matsumoto T; Saito T; Kadono Y; Okada H; Miyamoto T; Tamura T; Aburatani H; Tanaka S
    J Bone Miner Res; 2019 Jun; 34(6):1143-1154. PubMed ID: 30721543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation.
    Häusler KD; Horwood NJ; Chuman Y; Fisher JL; Ellis J; Martin TJ; Rubin JS; Gillespie MT
    J Bone Miner Res; 2004 Nov; 19(11):1873-81. PubMed ID: 15476588
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts.
    Takayanagi H; Kim S; Koga T; Nishina H; Isshiki M; Yoshida H; Saiura A; Isobe M; Yokochi T; Inoue J; Wagner EF; Mak TW; Kodama T; Taniguchi T
    Dev Cell; 2002 Dec; 3(6):889-901. PubMed ID: 12479813
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The calcineurin/nuclear factor of activated T cells signaling pathway regulates osteoclastogenesis in RAW264.7 cells.
    Hirotani H; Tuohy NA; Woo JT; Stern PH; Clipstone NA
    J Biol Chem; 2004 Apr; 279(14):13984-92. PubMed ID: 14722106
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Id helix-loop-helix proteins negatively regulate TRANCE-mediated osteoclast differentiation.
    Lee J; Kim K; Kim JH; Jin HM; Choi HK; Lee SH; Kook H; Kim KK; Yokota Y; Lee SY; Choi Y; Kim N
    Blood; 2006 Apr; 107(7):2686-93. PubMed ID: 16322470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Convergent signaling by acidosis and receptor activator of NF-kappaB ligand (RANKL) on the calcium/calcineurin/NFAT pathway in osteoclasts.
    Komarova SV; Pereverzev A; Shum JW; Sims SM; Dixon SJ
    Proc Natl Acad Sci U S A; 2005 Feb; 102(7):2643-8. PubMed ID: 15695591
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Comprehensive Review of Immunoreceptor Regulation of Osteoclasts.
    Humphrey MB; Nakamura MC
    Clin Rev Allergy Immunol; 2016 Aug; 51(1):48-58. PubMed ID: 26573914
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Upstream stimulatory factors regulate OSCAR gene expression in RANKL-mediated osteoclast differentiation.
    Kim JH; Kim K; Jin HM; Youn BU; Song I; Choi HS; Kim N
    J Mol Biol; 2008 Nov; 383(3):502-11. PubMed ID: 18762192
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IL-1R/TLR2 through MyD88 Divergently Modulates Osteoclastogenesis through Regulation of Nuclear Factor of Activated T Cells c1 (NFATc1) and B Lymphocyte-induced Maturation Protein-1 (Blimp1).
    Chen Z; Su L; Xu Q; Katz J; Michalek SM; Fan M; Feng X; Zhang P
    J Biol Chem; 2015 Dec; 290(50):30163-74. PubMed ID: 26483549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice.
    Kim SD; Kim HN; Lee JH; Jin WJ; Hwang SJ; Kim HH; Ha H; Lee ZH
    Biochem Pharmacol; 2013 Sep; 86(6):782-90. PubMed ID: 23928189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Esculetin attenuates receptor activator of nuclear factor kappa-B ligand-mediated osteoclast differentiation through c-Fos/nuclear factor of activated T-cells c1 signaling pathway.
    Baek JM; Park SH; Cheon YH; Ahn SJ; Lee MS; Oh J; Kim JY
    Biochem Biophys Res Commun; 2015 May; 461(2):334-41. PubMed ID: 25887803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Essential role of p38 mitogen-activated protein kinase in cathepsin K gene expression during osteoclastogenesis through association of NFATc1 and PU.1.
    Matsumoto M; Kogawa M; Wada S; Takayanagi H; Tsujimoto M; Katayama S; Hisatake K; Nogi Y
    J Biol Chem; 2004 Oct; 279(44):45969-79. PubMed ID: 15304486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transcriptional program of mouse osteoclast differentiation governed by the macrophage colony-stimulating factor and the ligand for the receptor activator of NFkappa B.
    Cappellen D; Luong-Nguyen NH; Bongiovanni S; Grenet O; Wanke C; Susa M
    J Biol Chem; 2002 Jun; 277(24):21971-82. PubMed ID: 11923298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin-4 inhibits RANKL-induced expression of NFATc1 and c-Fos: a possible mechanism for downregulation of osteoclastogenesis.
    Kamel Mohamed SG; Sugiyama E; Shinoda K; Hounoki H; Taki H; Maruyama M; Miyahara T; Kobayashi M
    Biochem Biophys Res Commun; 2005 Apr; 329(3):839-45. PubMed ID: 15752732
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of osteoclast differentiation by fibroblast growth factor 2: stimulation of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor expression in osteoblasts and inhibition of macrophage colony-stimulating factor function in osteoclast precursors.
    Chikazu D; Katagiri M; Ogasawara T; Ogata N; Shimoaka T; Takato T; Nakamura K; Kawaguchi H
    J Bone Miner Res; 2001 Nov; 16(11):2074-81. PubMed ID: 11697804
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MafB negatively regulates RANKL-mediated osteoclast differentiation.
    Kim K; Kim JH; Lee J; Jin HM; Kook H; Kim KK; Lee SY; Kim N
    Blood; 2007 Apr; 109(8):3253-9. PubMed ID: 17158225
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of NFAT binding sites that mediate stimulation of cathepsin K promoter activity by RANK ligand.
    Balkan W; Martinez AF; Fernandez I; Rodriguez MA; Pang M; Troen BR
    Gene; 2009 Oct; 446(2):90-8. PubMed ID: 19563866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.